Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A woman in Turkey with a scalp infection was cured using oral and topical antifungals after a recurrence due to not following the treatment properly.

Topical tofacitinib is effective and safe for treating alopecia areata.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

The research helps understand how finasteride works and aids drug development.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treats Alopecia Areata.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.